Patents by Inventor Douglas R. Storts

Douglas R. Storts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11939310
    Abstract: The present disclosure includes compositions and methods for improved DNA amplification reactions. In particular, the present disclosure provides compositions and methods for hot-start PCR applications using DNA polymerase inhibitors that minimize non-specific DNA amplification by inactivating DNA polymerase at lower temperatures.
    Type: Grant
    Filed: October 25, 2022
    Date of Patent: March 26, 2024
    Assignee: Promega Corporation
    Inventors: Wenhui Zhou, Kimberly K. Knoche, Douglas R. Storts, Min Zhou, Poncho Meisenheimer
  • Publication number: 20230382875
    Abstract: Provided herein are compounds, compositions, and methods for rapid isolation of nucleic acids from a sample.
    Type: Application
    Filed: April 21, 2023
    Publication date: November 30, 2023
    Inventors: Zhiyang Zeng, Wenhui Zhou, Douglas R. Storts, Poncho Meisenheimer, Ian Marozas, Andrew Taft, Spencer Hermanson, Connor Fitzgerald, Kasen Riemersma
  • Publication number: 20230097403
    Abstract: The present disclosure includes compositions and methods for improved DNA amplification reactions. In particular, the present disclosure provides compositions and methods for hot-start PCR applications using DNA polymerase inhibitors that minimize non-specific DNA amplification by inactivating DNA polymerase at lower temperatures.
    Type: Application
    Filed: October 25, 2022
    Publication date: March 30, 2023
    Inventors: Wenhui Zhou, Kimberly K. Knoche, Douglas R. Storts, Min Zhou, Poncho Meisenheimer
  • Patent number: 11524946
    Abstract: The present disclosure includes compositions and methods for improved DNA amplification reactions. In particular, the present disclosure provides compositions and methods for hot-start PCR applications using DNA polymerase inhibitors that minimize non-specific DNA amplification by inactivating DNA polymerase at lower temperatures.
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: December 13, 2022
    Assignee: Promega Corporation
    Inventors: Wenhui Zhou, Kimberly K. Knoche, Douglas R. Storts, Min Zhou, Poncho Meisenheimer
  • Publication number: 20200199088
    Abstract: The present disclosure includes compositions and methods for improved DNA amplification reactions. In particular, the present disclosure provides compositions and methods for hot-start PCR applications using DNA polymerase inhibitors that minimize non-specific DNA amplification by inactivating DNA polymerase at lower temperatures.
    Type: Application
    Filed: December 12, 2019
    Publication date: June 25, 2020
    Inventors: Wenhui Zhou, Kimberly K. Knoche, Douglas R. Storts, Min Zhou, Poncho Meisenheimer
  • Patent number: 6077664
    Abstract: The present invention relates to compositions of thermostable DNA polymerases derived from the hyperthermophilic eubacteria. In particular, the present invention comprises thermostable DNA polymerases from the hyperthermophilic eubacterium known as Thermotoga neapolitana. The present invention provides methods for utilizing naturally-occurring and non-naturally-occurring forms of T. neopolitana DNA polymerase. The T. neopolitana DNA polymerases of the present invention are used in combination with other compounds, including but not limited to pyrophosphatase and DNA polymerases from other thermophilic or hyperthermophilic organisms.
    Type: Grant
    Filed: May 31, 1996
    Date of Patent: June 20, 2000
    Assignee: Promega Corporation
    Inventors: Michael R. Slater, Fen Huang, James R. Hartnett, Elena Bolchakova, Douglas R. Storts, Paul Otto, Katharine M. Miller, Alexander Novikov, Galina A. Velikodvorskaya
  • Patent number: 5981235
    Abstract: Solutions containing nucleic acids are treated with an alkaline protease to digest proteins such as nucleases that degrade the nucleic acids. In the isolation of nucleic acids, a biological sample containing nucleic acids is suspended in a solution containing water, buffer and chelating agent, the pH of the solution is adjusted to at least about 10 by adding a solution of sodium hydroxide and anionic detergent, an alkaline protease is incubated in the solution until nucleases are degraded, the pH of the solution is lowered to reduce activity of the alkaline protease by adding a solution having a pH between 3.5 and 4.5 and the alkaline protease is heat inactivated. Lowering of the pH may produce a cloudy solution which is cleared by centrifuging. Nucleic acids are isolated from the cleared solution by alcohol precipitation, or by using paramagnetic particles or a resin matrix containing silica particles. A chaotropic salt can be used to reversibly bind DNA to the resin matrix.
    Type: Grant
    Filed: July 29, 1996
    Date of Patent: November 9, 1999
    Assignee: Promega Corporation
    Inventors: John Shultz, Craig E. Smith, Douglas R. Storts, Paula Brisco, Judy Frederiksen, Susanne Selman, Josephine Grosch
  • Patent number: 5654149
    Abstract: A new process and kit are described that combines methods for generating the nucleotide base sequence of a DNA molecule with an ultra-sensitive silver staining protocol. This new combination of technologies allows for a direct, non-instrument based visualization of electrophoretically separated sequencing fragments. This non-radioactive system includes sequencing the DNA molecule by forming a set of fragments using an enzymatic dideoxy-mediated chain termination method, electrophoretically separating the DNA fragments on a gel medium, and exposing the gel medium to ultra-sensitive silver-staining solutions for a time determined by viewing the silver stain reacted primer extension products.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 5, 1997
    Assignee: Promega Corporation
    Inventors: Leopoldo G. Mendoza, Douglas R. Storts
  • Patent number: 5523206
    Abstract: A new process and kit are described that combines methods for generating the nucleotide base sequence of a DNA molecule with an ultra-sensitive silver staining protocol. This new combination of technologies allows for a direct, non-instrument based visualization of electrophoretically separated sequencing fragments. This non-radioactive system includes sequencing the DNA molecule by forming a set of fragments using an enzymatic dideoxy-mediated chain termination method, electrophoretically separating the DNA fragments on a gel medium, and exposing the gel medium to ultra-sensitive silver-staining solutions for a time determined by viewing the silver stain reacted primer extension products.
    Type: Grant
    Filed: March 23, 1994
    Date of Patent: June 4, 1996
    Assignee: Promega Corporation
    Inventors: Leopoldo G. Mendoza, Douglas R. Storts